The multi-omics and Mendelian randomization analyses unveiled potential marker genes in the progression of glioblastoma.

In glioma research, identifying key molecules for predicting patient prognosis is challenging due to high heterogeneity. This study explores the correlation between alternative splicing (AS) and glioma prognosis, aiming to identify molecular markers…

Preview only. Read the full abstract at the source